{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:22:18Z","timestamp":1760145738510,"version":"build-2065373602"},"reference-count":76,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:00:00Z","timestamp":1724284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"the European Union\u2019s Horizon 2020 research and innovation program under the Marie Sklodowska-Curie","doi-asserted-by":"publisher","award":["812915","GK1949\/2","DR632\/2-1 project No 452147069"],"award-info":[{"award-number":["812915","GK1949\/2","DR632\/2-1 project No 452147069"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)","doi-asserted-by":"publisher","award":["812915","GK1949\/2","DR632\/2-1 project No 452147069"],"award-info":[{"award-number":["812915","GK1949\/2","DR632\/2-1 project No 452147069"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Chlamydia trachomatis remains a major global health problem with increasing infection rates, requiring innovative vaccine solutions. Modified Vaccinia Virus Ankara (MVA) is a well-established, safe and highly immunogenic vaccine vector, making it a promising candidate for C. trachomatis vaccine development. In this study, we evaluated two novel MVA-based recombinant vaccines expressing spCTH522 and CTH522:B7 antigens. Our results show that while both vaccines induced CD4+ T-cell responses in C57BL\/6J mice, they failed to generate antigen-specific systemic CD8+ T cells. Only the membrane-anchored CTH522 elicited strong IgG2b and IgG2c antibody responses. In an HLA transgenic mouse model, both recombinant MVAs induced Th1-directed CD4+ T cell and multifunctional CD8+ T cells, while only the CTH522:B7 vaccine generated antibody responses, underscoring the importance of antigen localization. Collectively, our data indicate that distinct antigen formulations can induce different immune responses depending on the mouse strain used. This research contributes to the development of effective vaccines by highlighting the importance of careful antigen design and the selection of appropriate animal models to study specific vaccine-induced immune responses. Future studies should investigate whether these immune responses provide protection in humans and should explore different routes of immunization, including mucosal and systemic immunization.<\/jats:p>","DOI":"10.3390\/vaccines12080944","type":"journal-article","created":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T07:53:37Z","timestamp":1724658817000},"page":"944","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Viral Vector-Based Chlamydia trachomatis Vaccines Encoding CTH522 Induce Distinct Immune Responses in C57BL\/6J and HLA Transgenic Mice"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-5072-0219","authenticated-orcid":false,"given":"Giuseppe","family":"Andreacchio","sequence":"first","affiliation":[{"name":"Institute of Virology, Universit\u00e4tsklinikum D\u00fcsseldorf, 40225 D\u00fcsseldorf, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ylenia","family":"Longo","sequence":"additional","affiliation":[{"name":"Institute of Virology, Universit\u00e4tsklinikum D\u00fcsseldorf, 40225 D\u00fcsseldorf, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara Moreno","family":"Moreno Mascaraque","sequence":"additional","affiliation":[{"name":"Institute of Virology, Universit\u00e4tsklinikum D\u00fcsseldorf, 40225 D\u00fcsseldorf, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kartikan","family":"Anandasothy","sequence":"additional","affiliation":[{"name":"Institute of Virology, Universit\u00e4tsklinikum D\u00fcsseldorf, 40225 D\u00fcsseldorf, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Tofan","sequence":"additional","affiliation":[{"name":"Institute of Virology, Universit\u00e4tsklinikum D\u00fcsseldorf, 40225 D\u00fcsseldorf, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esma","family":"\u00d6z\u00fcn","sequence":"additional","affiliation":[{"name":"Institute of Virology, Universit\u00e4tsklinikum D\u00fcsseldorf, 40225 D\u00fcsseldorf, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lena","family":"Wilschrey","sequence":"additional","affiliation":[{"name":"Institute of Virology, Universit\u00e4tsklinikum D\u00fcsseldorf, 40225 D\u00fcsseldorf, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Ptok","sequence":"additional","affiliation":[{"name":"Institute of Virology, Universit\u00e4tsklinikum D\u00fcsseldorf, 40225 D\u00fcsseldorf, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dung T.","family":"Huynh","sequence":"additional","affiliation":[{"name":"R&D Department, Abera Bioscience AB, 75184 Uppsala, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joen","family":"Luirink","sequence":"additional","affiliation":[{"name":"R&D Department, Abera Bioscience AB, 75184 Uppsala, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6903-9144","authenticated-orcid":false,"given":"Ingo","family":"Drexler","sequence":"additional","affiliation":[{"name":"Institute of Virology, Universit\u00e4tsklinikum D\u00fcsseldorf, 40225 D\u00fcsseldorf, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,22]]},"reference":[{"key":"ref_1","unstructured":"(2021). Global Progress Report on HIV, Viral Hepatitis and Sexually Transmitted Infections, 2021. Accountability for the Global Health Sector Strategies 2016\u20132021: Actions for Impact, World Health Organization."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1016\/j.vaccine.2021.03.043","article-title":"Chlamydia trachomatis: Cell biology, immunology and vaccination","volume":"39","author":"Murray","year":"2021","journal-title":"Vaccine"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1469-0691.2008.02647.x","article-title":"Genital Chlamydia trachomatis infections","volume":"15","year":"2009","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/0956462414531243","article-title":"Risk for HIV following a diagnosis of syphilis, gonorrhoea or chlamydia: 328,456 women in Florida, 2000\u20132011","volume":"26","author":"Peterman","year":"2015","journal-title":"Int. J. STD AIDS"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1586\/14787210.2014.901169","article-title":"Lymphogranuloma venereum among men who have sex with men. An epidemiological and clinical review","volume":"12","year":"2014","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1086\/648734","article-title":"Repeated Chlamydia trachomatis Genital Infections in Adolescent Women","volume":"201","author":"Batteiger","year":"2010","journal-title":"J. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1017\/S0950268818002704","article-title":"Repeated Chlamydia trachomatis infections are associated with lower bacterial loads","volume":"147","author":"Gupta","year":"2019","journal-title":"Epidemiol. Infect."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Walker, J., Tabrizi, S.N., Fairley, C.K., Chen, M.Y., Bradshaw, C.S., Twin, J., Taylor, N., Donovan, B., Kaldor, J.M., and McNamee, K. (2012). Chlamydia trachomatis Incidence and Re-Infection among Young Women\u2014Behavioural and Microbiological Characteristics. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0037778"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/OLQ.0b013e318206c288","article-title":"The incidence and correlates of symptomatic and asymptomatic Chlamydia trachomatis and Neisseria gonorrhoeae infections in selected populations in five countries","volume":"38","author":"Detels","year":"2011","journal-title":"Sex. Transm. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1016\/j.vaccine.2013.01.024","article-title":"Chlamydia trachomatis Control Requires a Vaccine","volume":"31","author":"Brunham","year":"2013","journal-title":"Vaccine"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1086\/497341","article-title":"The unexpected impact of a Chlamydia trachomatis infection control program on susceptibility to reinfection","volume":"192","author":"Brunham","year":"2005","journal-title":"J. Infect. Dis."},{"key":"ref_12","first-page":"CD001860","article-title":"Antibiotics for trachoma","volume":"2019","author":"Evans","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1473-3099(19)30279-8","article-title":"Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: A first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial","volume":"19","author":"Abraham","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Singh, V., Salhan, S., Das, B.C., and Mittal, A. (2003). Predominance of Chlamydia trachomatis Serovars Associated with Urogenital Infections in Females in New Delhi, India. J. Clin. Microbiol., 41.","DOI":"10.1128\/JCM.41.6.2700-2702.2003"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"342","DOI":"10.7883\/yoken.63.342","article-title":"The Prevalence and Distribution of Chlamydia trachomatis Genotypes among Sexually Transmitted Disease Clinic Patients in Guangzhou, China, 2005\u20132008","volume":"63","author":"BYang","year":"2010","journal-title":"Jpn. J. Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Lesiak-Markowicz, I., Sch\u00f6tta, A.-M., Stockinger, H., Stanek, G., and Markowicz, M. (2019). Chlamydia trachomatis serovars in urogenital and ocular samples collected 2014\u20132017 from Austrian patients. Sci. Rep., 9.","DOI":"10.1038\/s41598-019-54886-5"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1093\/infdis\/jiv137","article-title":"Protection Against Chlamydia trachomatis Infection and Upper Genital Tract Pathological Changes by Vaccine-Promoted Neutralizing Antibodies Directed to the VD4 of the Major Outer Membrane Protein","volume":"212","author":"Olsen","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Nguyen, N.D.N.T., Guleed, S., Olsen, A.W., Follmann, F., Christensen, J.P., and Dietrich, J. (2021). Th1\/Th17 T cell Tissue-Resident Immunity Increases Protection, But Is Not Required in a Vaccine Strategy Against Genital Infection with Chlamydia trachomatis. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.790463"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1038\/s41467-024-45526-2","article-title":"Immune signature of Chlamydia vaccine CTH522\/CAF\u00ae01 translates from mouse-to-human and induces durable protection in mice","volume":"15","author":"Olsen","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.micinf.2008.08.006","article-title":"Role of CD8+ T cells in the host response to Chlamydia","volume":"10","author":"Wizel","year":"2008","journal-title":"Microbes Infect."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"ftab014","DOI":"10.1093\/femspd\/ftab014","article-title":"T cell responses to Chlamydia","volume":"79","author":"Helble","year":"2021","journal-title":"Pathog. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1365-2249.2004.02564.x","article-title":"Cytokine expression pattern in the genital tract of Chlamydia trachomatis positive infertile women\u2014Implication for T-cell responses","volume":"137","author":"BReddy","year":"2004","journal-title":"Clin. Exp. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/infdis\/jiw485","article-title":"Identification of Chlamydia trachomatis Antigens Recognized by T Cells From Highly Exposed Women Who Limit or Resist Genital Tract Infection","volume":"214","author":"Russell","year":"2016","journal-title":"J. Infect. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1084\/jem.20111266","article-title":"A live-attenuated chlamydial vaccine protects against trachoma in nonhuman primates","volume":"208","author":"Kari","year":"2011","journal-title":"J. Exp. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.4049\/jimmunol.1400120","article-title":"CD8+ T Cells Define an Unexpected Role in Live-Attenuated Vaccine Protective Immunity against Chlamydia trachomatis Infection in Macaques","volume":"192","author":"Whitmire","year":"2014","journal-title":"J. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.4049\/jimmunol.177.6.4021","article-title":"Chlamydia trachomatis Infection Alters the Development of Memory CD8+ T Cells","volume":"177","author":"Loomis","year":"2006","journal-title":"J. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.4049\/jimmunol.1500457","article-title":"An Excess of the Proinflammatory Cytokines IFN-\u03b3 and IL-12 Impairs the Development of the Memory CD8+ T Cell Response to Chlamydia trachomatis","volume":"195","author":"Zhang","year":"2015","journal-title":"J. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.4049\/jimmunol.1301657","article-title":"PD-L1 Limits the Mucosal CD8+ T Cell Response to Chlamydia trachomatis","volume":"192","author":"Fankhauser","year":"2014","journal-title":"J. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev-immunol-032712-095954","article-title":"Memory T Cell Subsets, Migration Patterns, and Tissue Residence","volume":"31","author":"Mueller","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e0045321","DOI":"10.1128\/IAI.00453-21","article-title":"Characterization of Pathogenic CD8+ T cells in Chlamydia-Infected OT1 Mice","volume":"90","author":"Zhou","year":"2022","journal-title":"Infect. Immun."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0092-8674(94)90169-4","article-title":"T cell receptor antagonist peptides induce positive selection","volume":"76","author":"Hogquist","year":"1994","journal-title":"Cell"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/2049-632X.12032","article-title":"OT-1 mice display minimal upper genital tract pathology following primary intravaginal Chlamydia muridarum infection","volume":"67","author":"Manam","year":"2013","journal-title":"Pathog. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1073\/pnas.1711356115","article-title":"Pathology after Chlamydia trachomatis infection is driven by nonprotective immune cells that are distinct from protective populations","volume":"115","author":"Lijek","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/mi.2010.58","article-title":"CXCR3 and CCR5 are both required for T cell-mediated protection against C. trachomatis infection in the murine genital mucosa","volume":"4","author":"Olive","year":"2011","journal-title":"Mucosal Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Kaynarcalidan, O., Mascaraque, S.M., and Drexler, I. (2021). Vaccinia Virus: From Crude Smallpox Vaccines to Elaborate Viral Vector Vaccine Design. Biomedicines, 9.","DOI":"10.3390\/biomedicines9121780"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.3390\/v6072735","article-title":"Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory Diseases","volume":"6","author":"Altenburg","year":"2014","journal-title":"Viruses"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1016\/j.vaccine.2018.03.091","article-title":"Inclusion of the murine IgG\u03ba signal peptide increases the cellular immunogenicity of a simian adenoviral vectored Plasmodium vivax multistage vaccine","volume":"36","author":"Fonseca","year":"2018","journal-title":"Vaccine"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Lin, Y.-C., Chen, B.-M., Lu, W.-C., Su, C.-I., Prijovich, Z.M., Chung, W.-C., Wu, P.-Y., Chen, K.-C., Lee, I.-C., and Juan, T.-Y. (2013). The B7-1 Cytoplasmic Tail Enhances Intracellular Transport and Mammalian Cell Surface Display of Chimeric Proteins in the Absence of a Linear ER Export Motif. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0075084"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1002\/eji.200425463","article-title":"A mouse model of human adaptive immune functions: HLA-A2.1-\/HLA-DR1-transgenic H-2 class I-\/class II-knockout mice","volume":"34","author":"Pajot","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"581","DOI":"10.3390\/vaccines2030581","article-title":"Gene Expression Driven by a Strong Viral Promoter in MVA Increases Vaccination Efficiency by Enhancing Antibody Responses and Unmasking CD8+ T Cell Epitopes","volume":"2","author":"Becker","year":"2014","journal-title":"Vaccines"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12985-019-1212-y","article-title":"Generation of recombinant MVA-norovirus: A comparison study of bacterial artificial chromosome- and marker-based systems","volume":"16","author":"Kugler","year":"2019","journal-title":"Virol. J."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Barnowski, C., Ciupka, G., Tao, R., Jin, L., Busch, D.H., Tao, S., and Drexler, I. (2020). Efficient Induction of Cytotoxic T Cells by Viral Vector Vaccination Requires STING-Dependent DC Functions. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.01458"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/14760584.2017.1306441","article-title":"Influence of protein fold stability on immunogenicity and its implications for vaccine design","volume":"16","author":"Scheiblhofer","year":"2017","journal-title":"Expert Rev. Vaccines"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.4049\/jimmunol.1402508","article-title":"Extent of Systemic Spread Determines CD8+ T Cell Immunodominance for Laboratory Strains, Smallpox Vaccines, and Zoonotic Isolates of Vaccinia Virus","volume":"195","author":"Flesch","year":"2015","journal-title":"J. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"6855","DOI":"10.4049\/jimmunol.162.11.6855","article-title":"Induction of HLA class I-restricted CD8+ CTLs specific for the major outer membrane protein of Chlamydia trachomatis in human genital tract infections","volume":"162","author":"Kim","year":"1999","journal-title":"J. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Orlova, O.V., Glazkova, D.V., Bogoslovskaya, E.V., Shipulin, G.A., and Yudin, S.M. (2022). Development of Modified Vaccinia Virus Ankara-Based Vaccines: Advantages and Applications. Vaccines, 10.","DOI":"10.3390\/vaccines10091516"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/14760584.2021.1899817","article-title":"Chlamydia trachomatis vaccines for genital infections: Where are we and how far is there to go?","volume":"20","author":"Darville","year":"2021","journal-title":"Expert Rev. Vaccines"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Phillips, S., Quigley, B.L., and Timms, P. (2019). Seventy Years of Chlamydia Vaccine Research\u2014Limitations of the Past and Directions for the Future. Front. Microbiol., 10.","DOI":"10.3389\/fmicb.2019.00070"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Ura, T., Takeuchi, M., Kawagoe, T., Mizuki, N., Okuda, K., and Shimada, M. (2022). Current Vaccine Platforms in Enhancing T-Cell Response. Vaccines, 10.","DOI":"10.3390\/vaccines10081367"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1073\/pnas.0711504105","article-title":"Discovery of CD8+ T cell epitopes in Chlamydia trachomatis infection through use of caged class I MHC tetramers","volume":"105","author":"Grotenbreg","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"4742","DOI":"10.4049\/jimmunol.171.9.4742","article-title":"An Inclusion Membrane Protein from Chlamydia trachomatis Enters the MHC Class I Pathway and Stimulates a CD8+ T Cell Response","volume":"171","author":"Starnbach","year":"2003","journal-title":"J. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1073\/pnas.262668999","article-title":"Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines","volume":"100","author":"Drexler","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nature13387","article-title":"A vaccine targeting mutant IDH1 induces antitumour immunity","volume":"512","author":"Schumacher","year":"2014","journal-title":"Nature"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Liu, H., Shen, W., Shu, J., Kou, Z., and Jin, X. (2017). A novel polyepitope vaccine elicited HIV peptide specific CD4+ T cell responses in HLA-A2\/DRB1 transgenic mice. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0184207"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e1524694","DOI":"10.1080\/2162402X.2018.1524694","article-title":"Therapeutic vaccination using minimal HPV16 epitopes in a novel MHC-humanized murine HPV tumor model","volume":"8","author":"Kruse","year":"2019","journal-title":"Oncoimmunology"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Le Vu, P., Vadakekolathu, J., Idri, S., Nicholls, H., Cavaignac, M., Reeder, S., Khan, M.A., Christensen, D., Pockley, A.G., and McArdle, S.E. (2022). A Mutated Prostatic Acid Phosphatase (PAP) Peptide-Based Vaccine Induces PAP-Specific CD8+ T Cells with Ex Vivo Cytotoxic Capacities in HHDII\/DR1 Transgenic Mice. Cancers, 14.","DOI":"10.3390\/cancers14081970"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Peng, S., Xing, D., Ferrall, L., Tsai, Y.-C., Hung, C.-F., and Wu, T.-C. (2022). Identification of human MHC-I HPV18 E6\/E7-specific CD8+ T cell epitopes and generation of an HPV18 E6\/E7-expressing adenosquamous carcinoma in HLA-A2 transgenic mice. J. Biomed. Sci., 29.","DOI":"10.1186\/s12929-022-00864-5"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/CJI.0b013e3181aee1b6","article-title":"A Novel Mouse Model for Evaluation and Prediction of HLA-A2-restricted CEA Cancer Vaccine Responses","volume":"32","author":"Conforti","year":"2009","journal-title":"J. Immunother."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"7536","DOI":"10.4049\/jimmunol.175.11.7536","article-title":"A Predominant Role for Antibody in Acquired Immunity to Chlamydial Genital Tract Reinfection","volume":"175","author":"Morrison","year":"2005","journal-title":"J. Immunol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"8153","DOI":"10.1128\/IAI.73.12.8153-8160.2005","article-title":"Vaccination with the Chlamydia trachomatis Major Outer Membrane Protein Can Elicit an Immune Response as Protective as That Resulting from Inoculation with Live Bacteria","volume":"73","author":"Pal","year":"2005","journal-title":"Infect. Immun."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Ardizzone, C.M., Albritton, H.L., Lillis, R.A., Bagnetto, C.E.L., Shen, L., Cavacini, L.A., Kozlowski, P.A., and Quayle, A.J. (2021). Human genital antibody-mediated inhibition of Chlamydia trachomatis infection and evidence for ompA genotype-specific neutralization. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0258759"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"aaa8205","DOI":"10.1126\/science.aaa8205","article-title":"A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells","volume":"348","author":"Stary","year":"2015","journal-title":"Science"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41541-020-0157-x","article-title":"Parenteral vaccination protects against transcervical infection with Chlamydia trachomatis and generate tissue-resident T cells post-challenge","volume":"5","author":"Nguyen","year":"2020","journal-title":"NPJ Vaccines"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41577-023-00853-1","article-title":"Assessing the generation of tissue resident memory T cells by vaccines","volume":"23","author":"Rotrosen","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1084\/jem.20160888","article-title":"Antigen-dependent competition shapes the local repertoire of tissue-resident memory CD8+ T cells","volume":"213","author":"Muschaweckh","year":"2016","journal-title":"J. Exp. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1128\/IAI.01378-15","article-title":"Tissue-Resident T Cells as the Central Paradigm of Chlamydia Immunity","volume":"84","author":"Johnson","year":"2016","journal-title":"Infect. Immun."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e1221","DOI":"10.1016\/S2214-109X(17)30393-5","article-title":"Global causes of blindness and distance vision impairment 1990\u20132020: A systematic review and meta-analysis","volume":"5","author":"Flaxman","year":"2017","journal-title":"Lancet Glob Health"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41541-021-00312-9","article-title":"A Chlamydia trachomatis VD1-MOMP vaccine elicits cross-neutralizing and protective antibodies against C\/C-related complex serovars","volume":"6","author":"Olsen","year":"2021","journal-title":"NPJ Vaccines"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.vaccine.2013.10.016","article-title":"Towards a safe and effective chlamydial vaccine: Lessons from the eye","volume":"32","author":"Mabey","year":"2014","journal-title":"Vaccine"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S1473-3099(24)00147-6","article-title":"An investigation of trachoma vaccine regimens by the chlamydia vaccine CTH522 administered with cationic liposomes in healthy adults (CHLM-02): A phase 1, double-blind trial","volume":"24","author":"Pollock","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"ofac524","DOI":"10.1093\/ofid\/ofac524","article-title":"A Case Study of Zoonotic Chlamydia abortus Infection: Diagnostic Challenges From Clinical and Microbiological Perspectives","volume":"9","author":"Burgener","year":"2022","journal-title":"Open Forum Infect. Dis."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3201\/eid2603.191417","article-title":"Chlamydia abortus in Pregnant Woman with Acute Respiratory Distress Syndrome","volume":"26","author":"Pichon","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"7186","DOI":"10.1128\/IAI.68.12.7186-7189.2000","article-title":"Disease Outcome Subsequent to Primary and Secondary Urogenital Infection with Murine or Human Biovars of Chlamydia trachomatis","volume":"68","author":"Ramsey","year":"2000","journal-title":"Infect. Immun."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.micinf.2012.12.001","article-title":"Differences in infectivity and induction of infertility: A comparative study of Chlamydia trachomatis strains in the murine model","volume":"15","author":"Carmichael","year":"2013","journal-title":"Microbes Infect."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1128\/IAI.00357-13","article-title":"Animal Models for Studying Female Genital Tract Infection with Chlamydia trachomatis","volume":"81","author":"Kalmar","year":"2013","journal-title":"Infect. Immun."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"675360","DOI":"10.1155\/2011\/675360","article-title":"Nonhuman Primate Models Used to Study Pelvic Inflammatory Disease Caused by Chlamydia trachomatis","volume":"2011","author":"Bell","year":"2011","journal-title":"Infect. Dis. Obstet. Gynecol."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/12\/8\/944\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:41:01Z","timestamp":1760110861000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/12\/8\/944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,22]]},"references-count":76,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["vaccines12080944"],"URL":"https:\/\/doi.org\/10.3390\/vaccines12080944","relation":{},"ISSN":["2076-393X"],"issn-type":[{"type":"electronic","value":"2076-393X"}],"subject":[],"published":{"date-parts":[[2024,8,22]]}}}